Objective: To identify women who are most likely to benefit from primary prevention strategies for postpartum hemorrhage (PPH).
Introduction
Postpartum hemorrhage (PPH) remains a leading cause of pregnancy-related death in the United States. 1 It is largely due to uterine atony, which complicates about 5% of deliveries. Severe cases are usually recognized intraoperatively or within the first hour after vaginal delivery, although 'late' PPH occasionally occurs more than 24 h after delivery and may be because of retained products of conception, subinvolution of the placental site, infection or coagulopathy. 2 Serious morbidity arising from PPH also includes but is not limited to hysterectomy, hypovolemic shock, disseminated intravascular coagulopathy, renal failure, hepatic failure, adult respiratory distress syndrome, and Sheehan's syndrome. 3 Global initiatives to reduce maternal mortality and to decrease maternal morbidity in obstetrics have focused on strategies for the management of PPH, specifically emphasizing the active management of the third stage of labor, including the use of uterotonics immediately after the birth of the baby. 4 The need for standardized treatment protocols has been emphasized recently, although which uterotonics should be used remains controversial. 5, 6 Many hospitals currently run drills to train their staff using standardized protocols to recognize and treat PPH. 7, 8 Although the emphasis to date has been on early diagnosis and treatment, primary prevention of PPH has remained elusive. Numerous risk factors for PPH have been identified, and include conditions associated with uterine overdistention (e.g. multiple gestation, polydydramnios), prolonged second and third stages of labor, use of oxytocin or tocolytic agents, abnormal placentation, chorioamnionitis and instrumental delivery. 9 Given these multiple and disparate causes of PPH, primary prevention strategies have been lacking. The objective of this study is to create clinical profiles of women at risk for PPH for the purpose of identifying those women who are most at risk. Such information could subsequently be applied to the generation and evaluation of institutionally specific strategies for PPH prevention.
Methods
We conducted a retrospective cohort study of all births that occurred between August 1995 and February 2004 in a single Southern California hospital. This hospital is a teaching institution with a patient population that is ethnically diverse and largely socioeconomically disadvantaged. The hospital has maintained a comprehensive delivery database that included pregnancy, labor and delivery data abstracted from the medical chart review. These records were matched to administrative records containing International Classification of Diseases, Version 9 codes to obtain data regarding maternal and neonatal outcomes during hospitalization. Women with stillborns, fetuses weighing <500 g and multiple gestations had been excluded from the original dataset. Because this study was intended to focus on typical obstetrical patients, additional exclusions specific to this study were placenta accreta, percreta or increta, and placental abruption, as these diagnoses would likely be a 'trigger' associated with altered management, including heightened surveillance immediately postpartum.
The primary study outcome is PPH, defined as an estimated blood loss (EBL) of 1000 ml or greater, which is consistent with the recommendation of the World Health Organization, and is based on experience showing that blood loss up to 1000 ml may be considered to be physiological, and that, for healthy women 1000 ml is the physiological point at which a woman's vital signs may be affected. 10, 11 Nevertheless, PPH has been variably defined as having: (1) an EBL X500 ml; 9 (2) an EBL X1000 ml; 12 (3) an EBL X500 ml for vaginal deliveries and X1000 ml for cesarean deliveries 13 and (4) an EBL X1500 ml. 14 For completeness, we evaluated the relationships between these different case definitions for PPH and a composite measure of clinically significant 'severe' outcomes that consisted of maternal death, cardiovascular events, renal failure, disseminated intravascular coagulation and hysterectomy, as defined by International Classification of Diseases, Version 9 codes.
Using data abstracted from the medical chart review, we identified clinical conditions or risk factors that could be associated with PPH (Table 1) . The study population was stratified into three clinical groups: vaginal delivery, primary cesarean delivery and repeat cesarean delivery. Prolonged second stage of labor was defined as a second stage labor X3 or X2 h for primiparous women with and without an epidural, respectively, as per the definition used by the American College of Obstetricians and Gynecologists. 15 For multiparous women, this definition changed to X2 and X1 h depending on the use of regional anesthesia. Prolonged second stage could not be included in the cesarean models as the majority of women delivered by cesarean were delivered before labor, or during the first stage of labor. Instead, the variable 'cesarean performed during second stage' was used to capture the timing of the cesarean birth. The majority of cesarean deliveries are secondary to dystocia, either 'arrest of dilatation,' which is during the first stage, or 'arrest of descent,' which is during the second stage. Overall, fewer than 15% of all primary cesareans are performed for fetal distress. 16 For each delivery group, recursive partitioning algorithms (RPA) were used to examine the relationship of the clinical factors to PPH, and to ascertain which women were most at risk for hemorrhage. Recursive partitioning is a nonparametric technique that produces a classification or decision tree in which subjects are assigned to mutually exclusive subsets according to a set of predictor variables. 17, 18 It identifies subject subgroups with varying risks and may uncover interactions between predictors that may be overlooked in the traditional application of logistic regression to datasets with numerous predictors, as in our case. The decision tree was constructed by splitting subsets of the dataset using all predictor variables to create two or more child nodes repeatedly, beginning with the entire dataset. The predictor having the highest association with the target variable was selected for splitting. The association between each predictor variable and the target was computed using the analysis of variance F-test (for ordinal and continuous predictors) or Pearson's w-square test (for nominal predictors). Once these clinical factors and their interactions were identified, multivariable logistic regression models were built for each group using these clinical factors as covariates, and odds ratios (ORs) and 95% confidence intervals (CIs) for each factor were calculated. We theorized that these factors could then be used to identify women at the greatest risk for PPH, and could be used to develop strategies for prevention, which may include closer supervision and/or earlier intervention. We calculated the number of at-risk women who would need to be 'treated' under a prevention protocol to prevent one case of PPH. We report the 'number needed to treat' with 95% CIs for patients with one risk factor and patients with two risk factors (relative to patients without any risk factors) within each of the three delivery groups. The estimated probabilities for PPH used in these calculations were derived from the respective logistic regression models. All analyses were performed using the Statistical Analysis Software (Version 9.1, Statistical Analysis System (SAS) Institute Inc., Cary, NC, USA) with the exception of the RPA specifying the decision tree, which was constructed using the Answer Tree module of the Statistical Package for the Social Sciences (SPSS Inc., Chicago, IL, USA). The study was approved by the Institutional Review Board of the participating hospital.
Results
A total of 23 673 deliveries occurred during the study period, and of these, 21 867 (92.4%) were matched to administrative records for both mother and baby. After the clinical exclusions noted above, 20 746 deliveries (94.9%) formed the final study population. Of these, 16 218 (78.2%) were vaginal deliveries, 2696 (13.0%) were primary cesarean deliveries and 1832 (8.8%) were repeat cesarean deliveries. Table 2 describes the variation in clinically significant 'severe' maternal outcomes with various definitions of PPH from the literature. Overall, 4.4% of the study population had an EBL X1000 ml; among these, 2.5% experienced a severe maternal outcome. Using the definition of EBL X1000 ml, women with PPH were 19 times more likely to have a severe maternal outcome compared with women who did not have PPH (ORs 19.53; 95% CIs 11.10 to 34.36), and were 40 times more likely to have an erythrocyte transfusion compared with women who did not have PPH (ORs 40.00; 95% CIs 22.73 to 70.42).
Of the 16 218 vaginal deliveries, 122 (0.8%) were complicated by PPH. Data on the duration of the second stage of labor were missing for 2385 deliveries, largely because many of these women entered the hospital during the second stage. Owing to the importance of including prolonged second stage in the model, these deliveries were excluded from further analyses, yielding a total of 13 833 vaginal deliveries. RPA and multivariable logistic regression equations were then used to identify and quantify the most significant risk factors for PPH complicating vaginal deliveries.
Five clinical risk factors emerged from this analysis: prolonged second stage, macrosomia with maternal diabetes, macrosomia without maternal diabetes, manual removal of placenta and the use of magnesium sulfate. These risk factors were then evaluated simultaneously in the multivariate model described in Table 3 , which lists the ORs and 95% CIs for each of the covariates.
Of the 2696 primary cesarean deliveries, 505 (18.7%) were complicated by PPH. Our analysis identified the four most significant risk factors for PPH: cesarean during second stage, macrosomia, chorioamnionitis and multiparity (Table 3) . Abbreviation: CS, cesarean; EBL, estimated blood loss. a Severe maternal outcome was defined using administrative data (International Classification of Diseases, Version 9 (ICD-9) codes) as a composite of maternal death, cardiovascular events, renal failure, disseminated intravascular coagulation and hysterectomy. Of the 1832 repeat cesarean deliveries, 294 (16.0%) were complicated by PPH. RPA identified the three most significant risk factors for PPH complicating repeat cesarean deliveries: advanced maternal age (X35 years), failed vaginal birth after cesarean and a uterine incision other than an uncomplicated low transverse incision (Table 3) . Table 4 presents the numbers of at-risk women needed to treat in order to prevent one case of PPH. In this context, a 'treatment' would be equivalent to participating in a prevention strategy. For vaginal delivery, 210 women with prolonged second stage would need to be treated in order to prevent one case of PPH. However, for women with maternal diabetes and fetal macrosomia, only 17 have to be treated in order to prevent one case of PPH. For primary cesarean delivery, 19 women with chorioamnionitis would need to be treated in order to prevent one case of PPH. However, for women with chorioamnionitis who underwent a cesarean delivery during the second stage (most of which were due to arrest of descent), only eight have to be treated in order to prevent one case of PPH.
Discussion
As quality improvement efforts intensify in maternal care, there is a need for targeted prevention strategies that can address PPH and other principal morbidities of childbirth. Information regarding which women are most at risk can be used to develop institutionally specific 'clinical triggers' for intervention, to decrease the occurrence of PPH, and lead to heightened surveillance of at-risk patients. If PPH can be anticipated and recognized promptly, maternal morbidity may be lessened. Numerous risk factors for PPH have been suggested earlier, and those we have identified here are not new. 13 However, the use of RPA allows us to highlight those clinical risk factors that appear to be most strongly associated with PPH so that those who provide care in childbirth can identify women at the highest risk. Moreover, whereas earlier studies examined these numerous clinical factors as independent risk factors for PPH, we were able to examine how these factors contribute to the risk of PPH in the presence of all the other risk factors, and identify those that were most important.
Here, we identified women at the highest risk for PPH by delivery route. The combination of risk factors that was important for each delivery route depended both on the prevalence of the risk factor and its strength. These methods thus focus on women most at risk in a typical obstetrical population, so that the hospital staff can determine where their vigilance and resources should be directed. The risk factors and their combinations uncovered here are consistent with the literature and with general obstetrical experience.
The clinical nature of PPH provides both primary and secondary prevention opportunities for the obstetrical staff. As primary prevention opportunities for PPH are not well understood, our results can only suggest a foundation for further study of the identified high-risk groups. For example, under a primary prevention protocol for women with anticipated vaginal deliveries, those with gestational diabetes and macrosomia could be monitored strictly using Friedman's Curve or a labor partogram to confirm that labor is progressing as expected. [19] [20] [21] These results also recognize that, all women with protraction disorders deserve prompt recognition, treatment and consideration for cesarean delivery sooner rather than later. Furthermore, the data indicate that compounding protracted labor with chorioamnionitis or a manual placental extraction, two circumstances that may in themselves be largely avoidable, greatly increases PPH risk. The high-risk groups identified here suggest multiple opportunities to guide hospitals in the development of 'best practices' for routine obstetrics.
Under a secondary prevention protocol, high-risk patients might benefit from increased nursing vigilance immediately postpartum and/or an empirical prophylactic uterotonic treatment regimen. The frequency and duration of nursing assessments could perhaps be extended, and nursing communication between the staff on labor and delivery and the postpartum ward could specify that the patient is at increased risk for PPH, and monitored accordingly. Strategies to decrease the prevalence of these key risk factors could also be undertaken, for example, concentrating on reducing risks for infection and manual extraction of the placenta.
This retrospective study was undertaken in a single institution, which limits the generalizability of our findings not only because they are dependent on an individual particular study population and set of management and prevention practices, but also because they depend on the nature and accuracy of the data recorded at this institution. Some of the CIs of the ORs are wide for these rarer combinations of risk factors and may limit generalizability to other institutions. Nevertheless, the ability to evaluate such a high volume of obstetrical patients with consistent management has allowed us to examine the potential impact of numerous risk factors on PPH, and to estimate the occurrence of rare but severe maternal outcomes.
The dependence of the diagnosis of PPH on the subjective EBL estimate inherently limits our findings. As 500 ml is now understood to be an average EBL for women in normal labor, the current adoption of 1000 ml provides a more clinically relevant definition, 10, 11 and a definition that is associated with substantial maternal morbidity in our own data. As noted by the World Health Organization, the '500 ml limit should be considered an alert line; the action line is then reached when vital functions of the woman are endangered. In healthy women this usually only occurs after blood loss >1000 ml. 10 ' Further, it has the advantage of being standard across delivery method.
In this paper, we provide clinical profiles of women who might benefit the most from both primary and secondary PPH prevention strategies. This work suggests several avenues by which institutions may use these results to assist in monitoring at-risk women and in developing their own prevention strategies to reduce the occurrence and morbidity of PPH. Our study suggests that individualized patient-specific risk assessment for PPH may serve as a trigger for initiating institutional-specific PPH prevention strategies. As we seek improvement in maternal quality of care, we should not limit our efforts to improved early diagnosis and treatment of PPH, but rather, we should seek the development of strategies for primary prevention of PPH. Preventing PPH provides a substantial opportunity to decrease maternal morbidity and mortality and thereby improve overall childbirth outcomes.
